BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20022648)

  • 1. Modelling collective effectiveness of voluntary vaccination with and without incentives.
    Rat-Aspert O; Fourichon C
    Prev Vet Med; 2010 Mar; 93(4):265-75. PubMed ID: 20022648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated approach to assessing the viability of eradicating BVD in Scottish beef suckler herds.
    McCormick BJ; Stott AW; Brülisauer F; Vosough Ahmadi B; Gunn GJ
    Vet Microbiol; 2010 Apr; 142(1-2):129-36. PubMed ID: 19942381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of symptoms associated with bovine herpesvirus 1 vaccination].
    van Wuijckhuise L; Frankena K; van Oijen MA; Meijer L
    Tijdschr Diergeneeskd; 2001 Mar; 126(6):173-80. PubMed ID: 11285635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Control of bovine viral diarrhea/mucosal disease in the district of Kamenz on a voluntary basis--ways, successes, limitations].
    Brützke A; Donat K; Truyen U
    Berl Munch Tierarztl Wochenschr; 2011; 124(1-2):48-57. PubMed ID: 21309165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expected utility of voluntary vaccination in the middle of an emergent Bluetongue virus serotype 8 epidemic: a decision analysis parameterized for Dutch circumstances.
    Sok J; Hogeveen H; Elbers AR; Velthuis AG; Oude Lansink AG
    Prev Vet Med; 2014 Aug; 115(3-4):75-87. PubMed ID: 24768508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practices and opinions of New Zealand beef cattle farmers towards bovine viral diarrhoea control in relation to real and perceived herd serological status.
    Gates MC; Evans CA; Han JH; Heuer C; Weston JF
    N Z Vet J; 2020 Mar; 68(2):92-100. PubMed ID: 31722187
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of vaccination against Aujeszky's disease compared with test and slaughter programme: epidemiological and economical evaluations.
    Willeberg P; Leontides L; Ewald C; Mortensen S; McInerney JP; Howe KS; Kooij D
    Acta Vet Scand Suppl; 1996; 90():25-51. PubMed ID: 8996885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a benefit function to assess the relative investment potential of alternative farm animal disease prevention strategies.
    Stott AW; Gunn GJ
    Prev Vet Med; 2008 May; 84(3-4):179-93. PubMed ID: 18243379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling and costing BVD outbreaks in beef herds.
    Gunn GJ; Stott AW; Humphry RW
    Vet J; 2004 Mar; 167(2):143-9. PubMed ID: 14975388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of two-step vaccination in the control of bovine viral diarrhoea (BVD).
    Moennig V; Eicken K; Flebbe U; Frey HR; Grummer B; Haas L; Greiser-Wilke I; Liess B
    Prev Vet Med; 2005 Nov; 72(1-2):109-14; discussion 215-9. PubMed ID: 16169620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ten years of bovine virus diarrhoea virus (BVDV) control in Norway: a cost-benefit analysis.
    Valle PS; Skjerve E; Martin SW; Larssen RB; Østerås O; Nyberg O
    Prev Vet Med; 2005 Nov; 72(1-2):189-207; discussion 215-9. PubMed ID: 16213612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the results of a survey of dairy producers on dairy herd biosecurity and vaccination against bovine viral diarrhea.
    Rauff Y; Moore DA; Sischo WM
    J Am Vet Med Assoc; 1996 Nov; 209(9):1618-22. PubMed ID: 8899031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated BVDV-prevalence, -contact and -vaccine use in dairy herds in Northern Portugal.
    Niza-Ribeiro J; Pereira A; Souza J; Madeira H; Barbosa A; Afonso C
    Prev Vet Med; 2005 Nov; 72(1-2):81-5; discussion 215-9. PubMed ID: 16216353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the epidemiological and economic consequences of control scenarios for bovine viral diarrhea virus in dairy herds.
    Santman-Berends IM; Mars MH; van Duijn L; van Schaik G
    J Dairy Sci; 2015 Nov; 98(11):7699-716. PubMed ID: 26364098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal risk management versus willingness to pay for BVDV control options.
    Santarossa JM; Stott AW; Humphry RW; Gunn GJ
    Prev Vet Med; 2005 Nov; 72(1-2):183-7; discussion 215-9. PubMed ID: 16169618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Perspectives on BVD eradication in Germany].
    Moennig V; Greiser-Wilke I
    Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):222-6. PubMed ID: 12784556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics in the epidemiology of bovine viral diarrhea virus (BVDV) of relevance to control.
    Lindberg A; Houe H
    Prev Vet Med; 2005 Nov; 72(1-2):55-73; discussion 215-9. PubMed ID: 16214248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [BVD approach: vaccination and eradication].
    Verberne LR
    Tijdschr Diergeneeskd; 2000 Apr; 125(7):218-21. PubMed ID: 10775986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of performance of dairy herds that were or were not vaccinated with a bovine herpes virus 1 marker vaccine in 1998].
    Bartels CJ; Barkema HW; Beiboer ML; Bouma A; Stegeman JA
    Tijdschr Diergeneeskd; 2001 Mar; 126(6):191-7. PubMed ID: 11285639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Practice-oriented control of BVD virus infection in cattle herds].
    Heckert HP; Hofmann W; Hollberg W; Körner E
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 1998 Jul; 26(4):193-9. PubMed ID: 9710920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.